NCT07256782 2025-12-01
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Recruiting
Qilu Pharmaceutical Co., Ltd.
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.